Navigation Links
Asterix's Roman foes -- Researchers have a better idea of how cancer cells move and grow
Date:3/11/2013

This press release is available in French.

Researchers at the University of Montreal's Institute for Research in Immunology and Cancer (IRIC) have discovered a new mechanism that allows some cells in our body to move together, in some ways like the tortoise formation used by Roman soldiers depicted in the Asterix series. Collective cell migration is an essential part of our body's growth and defense system, but it is also used by cancerous cells to disseminate efficiently in the body. "We have found a key mechanism that allows cells to coordinate their movement as a group and we believe that this mechanism is used by malignant cells in a number of cancers, including some types of breast, prostate and skin cancers" explained lead researcher Gregory Emery. Roman soldiers formed the tortoise, or testudo formation, by coming closely together and aligning their shields side-by-side in order to defend themselves as they broke their enemy lines.

"As for the Romans, if some cancerous cells are migrating efficiently, it is because their movements are tightly coordinated. To stop their progression, we have first to understand how they coordinate. Then, we will aim at blocking this coordination in cancer cells to abrogate cancer progression."

IRIC's scientists and their colleagues from the Johns Hopkins School of Medicine in Baltimore, USA studied the movement of the "border-cells" in the ovaries of fruit flies, a biological process that is well understood by scientists and that they can reproduce easily. Researchers often use these kinds of cells as a model to get insight into metastatic cell migration the process by which malignant cells leave the original tumor as they can be easily manipulated and observed. Researchers look at how chemicals known as proteins that our body produces influence what goes on in cells. In this study for instance, the researchers from IRIC were able to aim a laser with sufficient precision to activate or inactivate an engineered protein in a single living cell, and observe directly the consequences of these alterations.

They found that a protein known as Rab11 enables individual cells to sense what the others are doing and organize into a tight structure to move together. Rab11 achieves this by regulating another protein, called Moesin which is involved in controlling the shape and rigidity of cells. Reducing the level of Moesin reduces the cohesion of the cluster and impedes cell movement. "Here, we have identified a mechanism by which the cells share information to coordinate movements. By disrupting this mechanism, we are able to block their migration." Dr Emery explained.

Although the findings were in a specific kind of cells in an insect model, the proteins involved, Rab11 and Moesin, have already been shown to play a role in some human cancers. "This indicates that the new regulatory mechanism we identified in fly cells is most likely also important in human cancers," Dr. Emery said. "Our work will allow us to identify molecular targets to disrupt collective cell migration and hopefully to fight metastasis formation" he concludes.


'/>"/>

Contact: William Raillant-Clark
w.raillant-clark@umontreal.ca
514-343-7593
University of Montreal
Source:Eurekalert  

Related biology news :

1. The worlds most sensitive plasmon resonance sensor inspired by ancient Roman cup
2. Valentines Day tales of romance and chemistry
3. Ovarian tumor, with teeth and a bone fragment inside, found in a Roman-age skeleton
4. Impulsive micromanagers help plants to adapt, survive
5. Romancing the firefly
6. Researchers find alternative cholesterol-lowering drug for patients who cant tolerate statins
7. Researchers develop tools for discovering new species
8. University of Illinois researchers develop AFM-IR for nanometer scale chemical identification
9. IRB Barcelona researchers discover mechanism that regulates steroid hormone production in Drosophila
10. Researchers discover gateway in nucleus has a second important job no one noticed before
11. Researchers explain a key developmental mechanism for the first time in plants
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Asterix's Roman foes -- Researchers have a better idea of how cancer cells move and grow
(Date:2/2/2017)... , Feb. 2, 2017   TapImmune, ... clinical-stage immuno-oncology company specializing in the development of ... the treatment of cancer and metastatic disease, announced ... and GMP manufacturing of a second clinical lot ... targeting folate receptor alpha. The manufactured vaccine product ...
(Date:2/2/2017)... Feb. 1, 2017  Central to its deep ... advances worldwide, The Japan Prize Foundation today announced ... have pushed the envelope in their respective fields ... Three scientists are being recognized with the 2017 ... not only contribute to the advancement of science ...
(Date:1/31/2017)...  Spero Therapeutics, LLC, a biopharmaceutical company founded ... bacterial infections, today announced it has acquired a ... Bono Bio Ltd (PBB) to bolster its pipeline ... of Gram-negative bacteria.   The assets acquired have been ... group company. "The acquisition of these ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... Fla. , Feb. 16, 2017  MDNA ... revolutionizing the development of liquid biopsy tests based ... entered into an exclusive license agreement with its ... MDNA,s proprietary liquid biopsy test for prostate cancer, ... South Korea . This is the first ...
(Date:2/16/2017)... Mass. , Feb. 16, 2017   Biostage, ... the "Company"), a biotechnology company developing bioengineered organ implants ... esophagus, bronchus and trachea, announced today the closing on ... of 20,000,000 shares of common stock and warrants to ... proceeds of $8.0 million. The offering was priced at ...
(Date:2/16/2017)... Feb. 16, 2017  Champions Oncology, Inc. (NASDAQ: ... and sale of advanced technology solutions and products to ... announced the addition of new cohorts of PDX models ... models will expand Champions, product line in hepatocellular cancer, ... cancer, AML, and non-small cell lung cancer (including EGFR ...
(Date:2/16/2017)... and NEW YORK , Feb. ... near completion of their $7M Series B financing, adding ... of the $3.5M led by Mesa Verde Venture Partners ... These resources will be directed towards further accelerating commercial ... a comprehensive genomic profiling test and expanding the Paradigm ...
Breaking Biology Technology: